Abstract:Abstract Motivation Combination therapy has shown to improve therapeutic efficacy while reducing side effects. Importantly, it has become an indispensable strategy to overcome resistance in antibiotics, antimicrobials and anticancer drugs. Facing enormous chemical space and unclear design principles for small-molecule combinations, computational drug-combination design has not seen generative models to meet its potential to accelerate resistance-overcoming drug combination discovery. Results We have developed the first deep generative model for drug combination design, by jointly embedding graph-structured domain knowledge and iteratively training a reinforcement learning-based chemical graph-set designer. First, we have developed hierarchical variational graph auto-encoders trained end-to-end to jointly embed gene–gene, gene–disease and disease–disease networks. Novel attentional pooling is introduced here for learning disease representations from associated genes’ representations. Second, targeting diseases in learned representations, we have recast the drug-combination design problem as graph-set generation and developed a deep learning-based model with novel rewards. Specifically, besides chemical validity rewards, we have introduced novel generative adversarial award, being generalized sliced Wasserstein, for chemically diverse molecules with distributions similar to known drugs. We have also designed a network principle-based reward for disease-specific drug combinations. Numerical results indicate that, compared to state-of-the-art graph embedding methods, hierarchical variational graph auto-encoder learns more informative and generalizable disease representations. Results also show that the deep generative models generate drug combinations following the principle across diseases. Case studies on four diseases show that network-principled drug combinations tend to have low toxicity. The generated drug combinations collectively cover the disease module similar to FDA-approved drug combinations and could potentially suggest novel systems pharmacology strategies. Our method allows for examining and following network-based principle or hypothesis to efficiently generate disease-specific drug combinations in a vast chemical combinatorial space. Availability and implementation https://github.com/Shen-Lab/Drug-Combo-Generator. Supplementary information Supplementary data are available at Bioinformatics online.

Drug combination synergistic effect determination method based on gene network

Exploring Drug Combinations in Genetic Interaction Network

Neighbor Communities in Drug Combination Networks Characterize Synergistic Effect.

Dcdb: Drug Combination Database

Predicting drug synergy using a network propagation inspired machine learning framework

A network-based trans-omics approach for predicting synergistic drug combinations

Prediction of Synergistic Anti-Cancer Drug Combinations Based on Drug Target Network and Drug Induced Gene Expression Profiles

DrugComboRanker: Drug Combination Discovery Based on Target Network Analysis

A Network Target-based Approach for Evaluating Multicomponent Synergy

Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations

Mechanisms of Drug Combinations: Interaction and Network Perspectives.

Systematic Analysis of New Drug Indications by Drug-Gene-Disease Coherent Subnetworks

Disease Gene Discovery of Single-Gene Disorders Based on Complex Network

Review of Predicting Synergistic Drug Combinations

Network target for screening synergistic drug combinations with application to traditional Chinese medicine

KGANSynergy: knowledge graph attention network for drug synergy prediction

Network-principled deep generative models for designing drug combinations as graph sets

Advances in computational approaches in identifying synergistic drug combinations.

Optimizing drug combination and mechanism analysis based on risk pathway crosstalk in pan cancer

A Co-Module Approach for Elucidating Drug-Disease Associations and Revealing Their Molecular Basis.

SynergyX: a multi-modality mutual attention network for interpretable drug synergy prediction